Significance of free and bound prostate-specific antigen

Endocrine-Related Cancer

Volumn 3, Issue 3, 1996, Pages 191-197

  Leinonen, J ^a   Stenman, U H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE; TUMOR MARKER;

ANTIGEN SPECIFICITY; CANCER DIAGNOSIS; COMPLEX FORMATION; EARLY DIAGNOSIS; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; IMMUNOREACTIVITY; MALE; PROSTATE CANCER; REVIEW;

EID: 0029998579     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0030191     Document Type: Review

References (44)

1. Babaian R, Fritsche H & Evans R 1990 Prostate-specific antigen and prostate gland volume: correlation and clinical application. Journal of Clinical Laboratory Analysis 4 135-137.
2. Bélanger A, van Halbeek H, Graves HCB, Grandbois K, Stamey TA, Lihua H, Poppe I & Labrie F 1995 Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate 27 187-197.
3. Bjartell A, Björk T, Matikainen MT, Abrahamsson PA, di Saint' Agnese A & Lilja H 1994 Production of alpha-1-antichymotrypsin by PSA-containing cells of the human prostatic epithelium. Urology 42 502-510.
4. Brawer MK, Schifman RB, Ahmann FR, Ahmann ME & Coulis KM 1988 The effect of digital rectal examination on serum levels of pro static-specific antigen. Archives of Pathology and Laboratory Medicine 112 1110-1112.
5. Breul J, Binder K, Block T & Hartung R 1992 Effect of digital rectal examination on serum concentration of prostate-specific antigen. European Urology 21 195-199.
6. Bridon D & Dowell B 1995 Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modelling. Urology 45 801-806.
7. Catalona W, Smith D, Ratliff T, Dodds K, Coplen D, Yuan J, Petros J & Andriole G 1991 Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New England Journal of Medicine 324 1156-1161.
8. Catalona W, Smith D, Wolfert R, Wang T, Rittenhouse H & Ratliff T 1995 Increased specificity of PSA screening through measurement of percent free PSA in serum. Journal of Urology 153 312A (Abstract 334).
9. Christensson A, Laurell C & Lilja H 1990 Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. European Journal of Biochemistry 194 755-763.
10. Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen M, Cockett A, Abrahamsson P & Lilja H 1993 Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. Journal of Urology 150 100-105.
11. Chybowski F, Bergstralh E & Oesterling J 1992 The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study. Journal of Urology 148 83-86.
12. Clements A & Mukhtar A 1994 Glandular kallikreins and prostate specific antigen are expressed in the human endometrium. Journal of Clinical Endocrinology and Metabolism 78 1536-1539.
13. Cohen P, Graves H, Peehl D, Kamarei M, Giudice L & Rosenfeld R 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. Journal of Clinical Endocrinology and Metabolism 75 1046-1053.
14. Dejter S, Martin J, McPherson R & Lynch J 1988 Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation. Urology 32 288-292.
15. Diamandis E, Yu H & Sutherland D 1994 Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Research and Treatment 32 291-300.
16. Frazier H, Humphrey P, Burchette J & Paulson D 1992 Immunoreactive prostatic specific antigen in male periurethral glands. Journal of Urology 147 246-248.
17. Gonias S, Balber A, Hubbard W & Pizzo S 1983 Ligand binding, conformational change and plasma elimination of human, mouse and rat α-macroglobulin proteinase inhibitors. Biochemical Journal 209 99-105.
18. Hara M, Koyanagi Y, Inoue T & Fukuyama T 1971 Physico-chemical characterization of γ-seminoprotein, an antigenic component specific for human seminal plasma. Japanese Journal of Legal Medicine 25 322-324.
19. Henttu P & Vihko P 1989 cDNA coding for the entire prostate specific antigen shows high homologies to the human tissue kallikrein genes. Biochemical and Biophysical Research Communications 160 903-910.
20. Jacobsen S, Klee G, Lilja H, Wright G & Oesterling J 1995 Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time. Urology 45 447-453.
21. Kamoshida S & Tsutsumi Y 1990 Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: Distribution in cloagenic glandular epithelium and sex-dependent expression in human anal gland. Human Pathology 21 1108-1111.
22. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomez JL & Emond J 1992 Serum prostate specific antigen as pre-screening test for prostate cancer. Journal of Urology 147 846-852.
23. Leinonen J, Lövgren T, Vornanen T & Stenman U-H 1993 Double-label time-resolved immunofluorometric assay of prostate-specific antigen and the complex between prostate-specific antigen with a-1-antichymotrypsin. Clinical Chemistry 39 2098-2103.
24. Leinonen J, Zhang W-M & Stenman U-H 1996 Complex formation between PSA isoenzymes and proteinase inhibitors. Journal of Urology 155 1099-1103.
25. Lilja H A 1985 Kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. Journal of Clinical Investigation 76 1899-1903.
26. Luderer A, Chen Y-T, Soriano T, Kramp W, Carlson G, Cuny C, Sharp T, Smith W, Petteway J, Brawer M & Thiel R 1995 Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 46 187-194.
27. Lundwall Å & Lilja H 1987 Molecular cloning of human prostate specific antigen cDNA. FEBS Letters 214 317-321.
28. Oesterling JE 1991 Prostate-specific antigen: a valuable clinical tool. Oncology Williston Park 5 107-122.
29. Oesterling J, Chan D, Epstein J, Kimball A, Bruzek D, Rock R, Brendler C & Walsh P 1988 Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. Journal of Urology 139 766-772.
30. Oesterling J, Jacobsen S, Klee G, Pettersson K, Piironen T, Abrahamsson P-A, Stenman U-H, Dowell B, Lövgren T & Lilja H 1995 Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios. Journal of Urology 154 1090-1095.
31. Oremek G & Seiffert U 1995 Influence of physical activity on PSA and PAP concentration in serum - the cut off value in tumor diagnostic has to be defined. XXIIIrd Meeting of the International Society for Oncodevelopmental Biology and Medicine. Abstract F8.
32. Pontes JE, Jabalameli P, Montie J, Foemmel R, Howard PD & Boyett J 1990 Prognostic implications of disappearance rate of biologic markers following radical prostatectomy. Urology 36 415-419.
33. Riegman P, Vliestra R, van der Korput J, Romijn J & Trapman J 1989 Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochemical and Biophysical Research Communications 159 95-102.
34. Schaller J, Akiyama K, Tsuda R, Hara M, Marti T & Rickli E 1987 Isolation, characterization and amino acid sequence of γ-seminoprotein, a glycoprotein from human seminal plasma. European Journal of Biochemistry 170 110-120.
35. Simak R, Madersbacher S, Zhang Z & Maier U 1993 The impact of ejaculation on serum prostate specific antigen. Journal of Urology 150 895-897.
36. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS & Redwine E 1987 Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New England Journal of Medicine 317 909-916.
37. 1-antichymotrypsin: influence of cancer volume, location and therapeutic selection of resistant clones. Journal of Urology 152 1510-1514.
38. Stenman U-H, Björses U-M & Leinonen J 1990 Time-resolved immunofluorometric assay of prostate-specific antigen. Journal of Nuclear Medicine and Allied Sciences 34 (Suppl 3) 249-251.
39. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K & Alfthan O 1991 A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer assay of the complex improves clinical sensitivity for cancer. Cancer Research 51 222-226.
40. Stenman U-H, Hakama M, Knekt P, Aromaa A, Teppo L & Leinonen J 1994 Serum concentrations of prostate specific antigen and its complex with α-1-antichymotrypsin before diagnosis of prostate cancer. Lancet 344 1594-1598.
41. Wang MC, Valenzuela LA, Murphy GP & Chu TM 1979 Purification of a human prostate specific antigen. Investigative Urology 17 159-163.
42. Watt K, Lee P-J, M'Timkulu T, Chan W & Loor R 1986 Human prostate specific antigen: structural and functional similarity with serine proteases. Proceedings of the National Academy of Sciences of the USA 83 3166-3170.
43. Zhang W-M, Leinonen J, Kalkkinen N, Dowell B & Stenman U-H 1995 Purification and characterization of different molecular forms of prostate specific antigen in human seminal fluid. Clinical Chemistry 41 1567-1573.
44. Zhou A, Tewari P, Bluestein B, Caldwell G & Larsen F 1993 Multiple forms of prostate-specific antigen in serum: Differences in immunorecognition by monoclonal and polyclonal assays. Clinical Chemistry 39 2483-2491.